Table 1. Comparison of Clinical and Laboratory Variables between MetS and Non-MetS Groups.
| Variable | MetS group (n=641) | Non-MetS group (n=271) | P value | Total |
|---|---|---|---|---|
| Age, yr | 58.6±12.8 | 58.1±13.4 | 0.59 | 58.4±0.4 |
| Male sex, % | 51.8 | 67.9 | <0.001 | 56.6 |
| Duration of diabetes, yr | 9.6±8.6 | 9.1±7.8 | 0.43 | 9.8±0.3 |
| Glycated hemoglobin, % | 9.2±2.3 | 9.4±2.8 | 0.342 | 9.3±0.1 |
| C-peptide, ng/mL | 2.9±0.1 | 1.9±1.1 | <0.001 | 2.6±0.1 |
| Body mass index, kg/m2 | 26.2±3.9 | 22.9±3.1 | <0.001 | 25.2±0.1 |
| Waist circumference, cm | 92.7±10.0 | 83.4±8.6 | <0.001 | 89.9±0.3 |
| Systolic blood pressure, mm Hg | 135.0±17.4 | 123.4±14.8 | <0.001 | 131.5±0.6 |
| Diastolic blood pressure, mm Hg | 81.4±10.7 | 76.3±9.1 | <0.001 | 79.9±0.3 |
| Triglyceride, mg/dL | 197.7±161.6 | 97.3±47.2 | <0.001 | 167.9±4.8 |
| HDL-C, mg/dL | 43.2±20.1 | 51.4±12.5 | <0.001 | 45.6±0.6 |
| LDL-C, mg/dL | 112.2±40.6 | 102.9±37.3 | 0.001 | 109.4±1.3 |
| Apolipoprotein B, mg/dL | 104.5±53.3 | 87.7±33.7 | <0.001 | 99.5±1.6 |
| hsCRP, mg/dL | 0.5±1.9 | 0.4±1.6 | 0.58 | 0.5±0.1 |
| Use of antilipidemic agents, % | 49.6 | 36.2 | <0.001 | 45 |
Values are expressed as mean±SD.
MetS, metabolic syndrome; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; hsCRP, high sensitivity C-reactive protein.